CHURCH & DWIGHT CO., INC. (CHD) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.29%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.13%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value 11.26×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.29% | Research and development expense / revenue. Period ending 2026-06-30. $142.50M ÷ $6.23B × 100 ≈ 2.29% |
| Stock-based compensation / revenue · 12 months | 1.13% | Share-based compensation / revenue. Period ending 2026-06-30. $70.40M ÷ $6.23B × 100 ≈ 1.13% |
| Interest coverage · 12 months | 11.26× | Operating income ÷ reported interest expense. $1.09B ÷ $96.60M ≈ 11.26× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 142.50M USD | Research and Development Expense |
| Revenue | 6.23B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 70.40M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.09B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 96.60M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $142.50M | $6.23B | $70.40M | $1.09B | $96.60M | 2.29% | 1.13% | 11.26× | Reported |
| 2026-03-31 | $144.40M | $6.21B | $63.00M | $1.07B | $95.90M | 2.33% | 1.02% | 11.19× | Reported |
| 2025-12-31 | $145.60M | $6.20B | $58.00M | $1.08B | $95.20M | 2.35% | 0.94% | 11.32× | Reported |
| 2025-09-30 | $145.40M | $6.14B | $52.80M | $1.07B | $94.00M | 2.37% | 0.86% | 11.36× | Reported |
| 2025-06-30 | $145.20M | $6.07B | $49.20M | $722.20M | $93.60M | 2.39% | 0.81% | 7.72× | Reported |
| 2025-03-31 | $142.40M | $6.07B | $51.00M | $797.40M | $93.30M | 2.35% | 0.84% | 8.55× | Reported |
| 2024-12-31 | $139.70M | $6.11B | $59.20M | $807.10M | $95.00M | 2.29% | 0.97% | 8.50× | Reported |
| 2024-09-30 | $134.30M | $6.05B | $62.70M | $766.50M | $98.60M | 2.22% | 1.04% | 7.77× | Reported |
| 2024-06-30 | $128.60M | $6.00B | $64.30M | $1.11B | $102.40M | 2.14% | 1.07% | 10.88× | Reported |
| 2024-03-31 | $125.80M | $5.94B | $66.70M | $1.07B | $107.10M | 2.12% | 1.12% | 10.00× | Reported |
| 2023-12-31 | $122.40M | $5.87B | $63.60M | $1.06B | $110.90M | 2.09% | 1.08% | 9.53× | Reported |
| 2023-09-30 | $116.30M | $579.30M | $61.80M | $642.90M | $113.90M | 20.08% | 10.67% | 5.64× | Reported |
| 2023-06-30 | $115.20M | $440.70M | $53.90M | $641.00M | $110.40M | 26.14% | 12.23% | 5.81× | Reported |
| 2023-03-31 | $112.20M | $311.60M | $55.20M | $609.00M | $101.80M | 36.01% | 17.72% | 5.98× | Reported |
| 2022-12-31 | $110.00M | $5.38B | $32.30M | $597.80M | $89.60M | 2.05% | 0.60% | 6.67× | Reported |
| 2022-09-30 | $108.90M | $5.31B | $25.40M | $972.60M | $72.60M | 2.05% | 0.48% | 13.40× | Reported |
| 2022-06-30 | $107.40M | $5.30B | $24.80M | $1.02B | $62.30M | 2.03% | 0.47% | 16.37× | Reported |
| 2022-03-31 | $105.60M | $5.25B | $23.50M | $1.06B | $57.10M | 2.01% | 0.45% | 18.51× | Reported |
| 2021-12-31 | $105.20M | $5.19B | $23.70M | $1.08B | $54.50M | 2.03% | 0.46% | 19.80× | Reported |
| 2021-09-30 | $106.50M | $5.12B | $23.10M | $1.09B | $55.50M | 2.08% | 0.45% | 19.70× | Reported |
| 2021-06-30 | $105.80M | $5.05B | $22.50M | $1.07B | $56.00M | 2.10% | 0.45% | 19.03× | Reported |
| 2021-03-31 | $105.00M | $4.97B | $21.90M | $1.02B | $58.70M | 2.11% | 0.44% | 17.34× | Reported |
| 2020-12-31 | $102.60M | $4.90B | $21.50M | $1.03B | $61.00M | 2.10% | 0.44% | 16.88× | Reported |
| 2020-09-30 | $99.30M | $4.74B | $21.80M | $1.03B | $65.00M | 2.09% | 0.46% | 15.91× | Reported |
| 2020-06-30 | $96.80M | $4.59B | $21.60M | $977.30M | $70.00M | 2.11% | 0.47% | 13.96× | Reported |
| 2020-03-31 | $94.60M | $4.48B | $21.10M | $914.00M | $72.10M | 2.11% | 0.47% | 12.68× | Reported |
| 2019-12-31 | $93.60M | $4.36B | $20.80M | $840.20M | $73.60M | 2.15% | 0.48% | 11.42× | Reported |
| 2019-09-30 | $92.90M | $4.29B | $21.20M | $838.40M | $75.30M | 2.17% | 0.49% | 11.13× | Reported |
| 2019-06-30 | $91.50M | $4.24B | $22.40M | $825.80M | $75.80M | 2.16% | 0.53% | 10.89× | Reported |
| 2019-03-31 | $90.90M | $4.18B | $22.60M | $812.20M | $77.10M | 2.17% | 0.54% | 10.53× | Reported |
| 2018-12-31 | $89.70M | $4.15B | $23.30M | $791.70M | $79.40M | 2.16% | 0.56% | 9.97× | Reported |
| 2018-09-30 | $87.10M | (m) | $23.00M | $813.00M | $78.40M | (m) | (m) | 10.37× | Reported |
| 2018-06-30 | $82.00M | (m) | $21.70M | $807.50M | $75.40M | (m) | (m) | 10.71× | Reported |
| 2018-03-31 | $76.20M | (m) | $19.20M | $756.90M | $64.50M | (m) | (m) | 11.73× | Reported |
| 2017-12-31 | $70.80M | (m) | $18.10M | $732.70M | $52.60M | (m) | (m) | 13.93× | Reported |
| 2017-09-30 | $66.30M | (m) | $16.80M | $691.40M | $40.90M | (m) | (m) | 16.90× | Reported |
| 2017-06-30 | $62.80M | (m) | $16.00M | $688.70M | $31.30M | (m) | (m) | 22.00× | Reported |
| 2017-03-31 | $62.90M | (m) | $12.20M | $740.80M | $29.10M | (m) | (m) | 25.46× | Reported |
| 2016-12-31 | $63.20M | (m) | $16.00M | $724.20M | $27.70M | (m) | (m) | 26.14× | Reported |
| 2016-09-30 | $61.60M | (m) | $16.00M | $720.00M | $28.30M | (m) | (m) | 25.44× | Reported |
| 2016-06-30 | $63.10M | (m) | $16.00M | $714.60M | $28.90M | (m) | (m) | 24.73× | Reported |
| 2016-03-31 | $65.30M | (m) | $20.20M | $681.60M | $29.70M | (m) | (m) | 22.95× | Reported |
| 2015-12-31 | $64.70M | (m) | $16.10M | $674.20M | $30.50M | (m) | (m) | 22.10× | Reported |
| 2015-09-30 | $65.60M | (m) | $16.20M | $668.80M | $29.80M | (m) | (m) | 22.44× | Reported |
| 2015-06-30 | $64.40M | (m) | $16.60M | $655.40M | $29.30M | (m) | (m) | 22.37× | Reported |
| 2015-03-31 | $60.50M | (m) | $16.40M | $651.30M | $28.30M | (m) | (m) | 23.01× | Reported |
| 2014-12-31 | $59.80M | (m) | $17.00M | $641.20M | $27.40M | (m) | (m) | 23.40× | Reported |
| 2014-09-30 | $59.10M | (m) | $17.40M | $622.00M | $27.20M | (m) | (m) | 22.87× | Reported |
| 2014-06-30 | $60.60M | (m) | $17.50M | $612.60M | $27.30M | (m) | (m) | 22.44× | Reported |
| 2014-03-31 | $60.50M | (m) | $17.60M | $614.90M | $27.40M | (m) | (m) | 22.44× | Reported |
| 2013-12-31 | $61.80M | (m) | $17.00M | $622.20M | $27.70M | (m) | (m) | 22.46× | Reported |
| 2013-09-30 | $59.60M | (m) | $16.40M | $612.20M | $27.30M | (m) | (m) | 22.42× | Reported |
| 2013-06-30 | $57.00M | (m) | $15.80M | $589.80M | $22.90M | (m) | (m) | 25.76× | Reported |
| 2013-03-31 | $56.60M | (m) | $12.60M | $571.70M | $18.30M | (m) | (m) | 31.24× | Reported |
| 2012-12-31 | $54.80M | (m) | $12.40M | $545.10M | $14.00M | (m) | (m) | 38.94× | Reported |
| 2012-09-30 | $55.60M | (m) | $11.90M | $527.90M | $8.90M | (m) | (m) | 59.31× | Reported |
| 2012-06-30 | $56.00M | (m) | $11.50M | $508.80M | $8.50M | (m) | (m) | 59.86× | Reported |
| 2012-03-31 | $55.20M | (m) | $10.70M | $504.20M | $8.70M | (m) | (m) | 57.95× | Reported |
| 2011-12-31 | $55.10M | (m) | $11.00M | $492.60M | $8.70M | (m) | (m) | 56.62× | Reported |
| 2011-09-30 | (m) | (m) | $11.45M | $455.25M | $13.78M | (m) | (m) | 33.04× | Reported |
| 2011-07-01 | (m) | (m) | $12.15M | $441.85M | $19.58M | (m) | (m) | 22.57× | Reported |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-04-01 | (m) | (m) | $11.85M | $444.05M | $22.28M | (m) | (m) | 19.93× | Reported |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $11.85M | $444.95M | $27.78M | (m) | (m) | 16.02× | Reported |
| 2010-10-01 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | $456.30M | (m) | (m) | (m) | (m) | (m) |
| 2010-07-02 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | $461.20M | (m) | (m) | (m) | (m) | (m) |
| 2010-04-02 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | $440.20M | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $12.73M | $412.89M | $35.57M | (m) | (m) | 11.61× | Reported |
| 2009-09-25 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-26 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-27 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | $12.41M | $340.33M | $46.95M | (m) | (m) | 7.25× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |